Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients (Q33979025)

30 July 2017

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients (English)

1 reference

30 July 2017

0 references

1 reference

Monia Raffa

1

1 reference

30 July 2017

Fatma Atig

2

1 reference

30 July 2017

Ahmed Mhalla

3

1 reference

30 July 2017

Abdelhamid Kerkeni

4

1 reference

30 July 2017

Anwar Mechri

5

1 reference

30 July 2017

language of work or name

1 reference

2 August 2011

1 reference

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

124

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-11-124

30 July 2017

0 references

cites work

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Oxidative stress in schizophrenia: an integrated approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Peripheral blood markers of oxidative stress in Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

The antioxidant glutathione peroxidase family and spermatozoa: a complex story

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Altered glutathione redox state in schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Cytotoxic and genotoxic potential of dopamine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Impaired antioxidant defense at the onset of psychosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Free radical pathology and antioxidant defense in schizophrenia: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

Dopamine in schizophrenia: a review and reconceptualization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3161936

A meta-analysis of oxidative stress markers in schizophrenia

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Study of plasma antioxidant status in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Validation of glutathione quantitation from STEAM spectra against edited 1H NMR spectroscopy at 4T: application to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Antioxidant enzyme activities and oxidative stress in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-11-124

Antioxidant status in the serum of persons with intellectual disability and hypothyroidism: A pilot study

21 January 2018

1 reference

12 December 2020

Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients

1 reference

12 December 2020

An improved coupled test procedure for glutathione peroxidase (EC 1-11-1-9-) in blood

1 reference

12 December 2020

Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase

1 reference

12 December 2020

48 Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples

1 reference

12 December 2020

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

12 December 2020

Human plasma glutathione peroxidase and symptom severity in schizophrenia

1 reference

12 December 2020

A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase

1 reference

12 December 2020

Total antioxidant response in patients with schizophrenia

1 reference

12 December 2020

Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects

1 reference

12 December 2020

Genetic polymorphism of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibility to schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-11-124

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference